IRON
Disc Medicine, Inc.
NASDAQ · Healthcare · Biotechnology · US
$79.23
−0.18%Jun 30, 2026, 00:00 UTC
Disc Medicine, Inc. amended its secured credit facility with Hercules Capital, Inc. on June 25, 2026, extending drawdown periods, splitting the $50 million Tranche 1-C Advance into two $25 million tranches, and drawing down $30 million of the Tranche 1-B Advance.
Jun 9, 2026, 12:30 UTC
Disc Medicine completed a Type A meeting with the FDA to discuss the Complete Response Letter for bitopertin in erythropoietic protoporphyria.
Source: